The Benefit Model for Prevention of Cardiovascular Disease: An Opportunity to Harmonize Guidelines.
Publication
, Journal Article
Thanassoulis, G; Pencina, MJ; Sniderman, AD
Published in: JAMA Cardiol
November 1, 2017
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
JAMA Cardiol
DOI
EISSN
2380-6591
Publication Date
November 1, 2017
Volume
2
Issue
11
Start / End Page
1175 / 1176
Location
United States
Related Subject Headings
- United States
- Smoking Cessation
- Risk Assessment
- Practice Guidelines as Topic
- Numbers Needed To Treat
- Hypertension
- Hypercholesterolemia
- Hydroxymethylglutaryl-CoA Reductase Inhibitors
- Humans
- Cholesterol, LDL
Citation
APA
Chicago
ICMJE
MLA
NLM
Thanassoulis, G., Pencina, M. J., & Sniderman, A. D. (2017). The Benefit Model for Prevention of Cardiovascular Disease: An Opportunity to Harmonize Guidelines. JAMA Cardiol, 2(11), 1175–1176. https://doi.org/10.1001/jamacardio.2017.2543
Thanassoulis, George, Michael J. Pencina, and Allan D. Sniderman. “The Benefit Model for Prevention of Cardiovascular Disease: An Opportunity to Harmonize Guidelines.” JAMA Cardiol 2, no. 11 (November 1, 2017): 1175–76. https://doi.org/10.1001/jamacardio.2017.2543.
Thanassoulis G, Pencina MJ, Sniderman AD. The Benefit Model for Prevention of Cardiovascular Disease: An Opportunity to Harmonize Guidelines. JAMA Cardiol. 2017 Nov 1;2(11):1175–6.
Thanassoulis, George, et al. “The Benefit Model for Prevention of Cardiovascular Disease: An Opportunity to Harmonize Guidelines.” JAMA Cardiol, vol. 2, no. 11, Nov. 2017, pp. 1175–76. Pubmed, doi:10.1001/jamacardio.2017.2543.
Thanassoulis G, Pencina MJ, Sniderman AD. The Benefit Model for Prevention of Cardiovascular Disease: An Opportunity to Harmonize Guidelines. JAMA Cardiol. 2017 Nov 1;2(11):1175–1176.
Published In
JAMA Cardiol
DOI
EISSN
2380-6591
Publication Date
November 1, 2017
Volume
2
Issue
11
Start / End Page
1175 / 1176
Location
United States
Related Subject Headings
- United States
- Smoking Cessation
- Risk Assessment
- Practice Guidelines as Topic
- Numbers Needed To Treat
- Hypertension
- Hypercholesterolemia
- Hydroxymethylglutaryl-CoA Reductase Inhibitors
- Humans
- Cholesterol, LDL